5,296 Shares in CME Group Inc. $CME Acquired by Royal Capital Wealth Management LLC

Royal Capital Wealth Management LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 5,296 shares of the financial services provider’s stock, valued at approximately $1,169,000. CME Group comprises 0.7% of Royal Capital Wealth Management LLC’s investment portfolio, making the stock its 27th largest position.

A number of other large investors have also recently added to or reduced their stakes in CME. Empowered Funds LLC increased its holdings in shares of CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after buying an additional 1,037 shares in the last quarter. Marshall Wace LLP raised its position in shares of CME Group by 103.1% during the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after purchasing an additional 121,707 shares during the period. Federated Hermes Inc. lifted its holdings in shares of CME Group by 1,325.2% during the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after purchasing an additional 21,918 shares during the last quarter. Nebula Research & Development LLC purchased a new stake in shares of CME Group during the second quarter valued at $992,000. Finally, The Manufacturers Life Insurance Company boosted its position in shares of CME Group by 2.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after purchasing an additional 7,397 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Insider Activity at CME Group

In related news, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The stock was acquired at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Up 1.5%

Shares of CME Group stock opened at $279.17 on Tuesday. The stock has a 50-day moving average price of $251.43 and a 200 day moving average price of $279.47. The company has a market cap of $100.38 billion, a P/E ratio of 23.68, a P/E/G ratio of 3.27 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the company posted $2.96 EPS. The business’s quarterly revenue was up .8% compared to the same quarter last year. As a group, analysts expect that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on CME shares. Raymond James Financial reissued an “outperform” rating and issued a $320.00 price target on shares of CME Group in a research note on Thursday, July 2nd. JPMorgan Chase & Co. raised their target price on shares of CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a report on Thursday, July 23rd. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a research report on Thursday, June 18th. Weiss Ratings lowered shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Finally, Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $316.00 to $323.00 in a research note on Thursday, June 11th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $288.56.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.